Trials / Completed
CompletedNCT05412654
Potassium Supplementation to Reduce Blood Pressure
Testing the Potential Effect of a Potassium-rich Water Intervention on Blood Pressure in Mild to Moderately Hypertensive Adults: a Double-blind Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Oxford Brookes University · Academic / Other
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to conduct a definitive trial to assess the efficacy of consuming 1L/day of water rich in potassium to reduce blood pressure in mild to moderately hypertensive adults. The objective is to assess the potential effect of the intervention on reducing systolic blood pressure. This study will comprise of a 4 week, double-blind, parallel randomised controlled trial. Participants will be adults with systolic blood pressure measurements of 130mmHg or greater. The intervention comprises advice to consume bottled water rich in potassium. The comparator will be regular bottled mineral water.This study will recruit 40 people with elevated systolic blood pressure (≥130mmHg) who are not regularly taking antihypertensive medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | High potassium water | High potassium water Potassium 6.2 mg/100ml |
| DIETARY_SUPPLEMENT | Control low potassium water | Control water Potassium 0.2 mg/100ml |
Timeline
- Start date
- 2022-07-30
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2022-06-09
- Last updated
- 2024-04-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05412654. Inclusion in this directory is not an endorsement.